miR-651-3p Enhances the Sensitivity of Hepatocellular Carcinoma to Cisplatin via Targeting ATG3-Mediated Cell Autophagy

<div>miR-651-3p increased the sensitivity of R-HepG2 cells on CDDP. (a) The viability of the R-HepG2 after serial dosage DDP treatment observed by CCK-8. (b) The apoptosis level of R-HepG2 with 5 <i>μ</i>M of CDDP measured by flow cytometry assay.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: miR-651-3p Enhances the Sensitivity of Hepatocellular Carcinoma to Cisplatin via Targeting ATG3-Mediated Cell Autophagy 